Palliative Care for Patients with Dementia

Description

A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York City, patients with advanced dementia and their family caregivers will be randomized to intervention or augmented control.

Conditions

Dementia

Talk to us

Study Overview

On this page

Study Details

Study overview

A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York City, patients with advanced dementia and their family caregivers will be randomized to intervention or augmented control.

Palliative Care At Home for Patients with Dementia and Their Caregivers

Palliative Care for Patients with Dementia

Condition
Dementia
Intervention / Treatment

-

Contacts and Locations

New York

Ichan School of Medicine at Mount Sinai, New York, New York, United States, 10029

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * have advanced dementia, based on Global Deterioration Score (GDS)\>6
  • * impairment in at least one activity of daily living (ADL -which is inherent in this level of GDS)
  • * at least one hospitalization or ED visit within the last 12 months
  • * a physician who is primarily responsible for their dementia-related care whose clinical outpatient site is associated with one of the four Mount Sinai sites in Manhattan
  • * a family caregiver willing to enroll
  • * a residence in Manhattan where they are currently living (not in a long-term care facility)
  • * capacity to consent or a legal representative available to provide consent
  • * fluency in English or Spanish, or their legal representative must be fluent in English or Spanish
  • * age \>64.
  • * Does not have a family caregiver to enroll
  • * Does not reside in Manhattan outside of long-term care facility
  • * Does not have fluency in English or Spanish Doesn't

Ages Eligible for Study

65 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Icahn School of Medicine at Mount Sinai,

Laura P Gelfman, MD, MPH, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

2027-08-31